Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/20/2020 11/23/2020 11/24/2020 11/25/2020 11/27/2020 Date
36.7(c) 36.52(c) 36.6(c) 36.53(c) 37.23(c) Last
60 633 847 43 673 118 42 485 263 26 955 795 25 245 002 Volume
+1.41% -0.49% +0.22% -0.19% +1.92% Change
More quotes
Financials (USD)
Sales 2020 49 265 M - -
Net income 2020 19 717 M - -
Net Debt 2020 35 033 M - -
P/E ratio 2020 18,5x
Yield 2020 4,03%
Sales 2021 54 646 M - -
Net income 2021 10 953 M - -
Net Debt 2021 31 703 M - -
P/E ratio 2021 16,3x
Yield 2021 4,13%
Capitalization 207 B 207 B -
EV / Sales 2020 4,91x
EV / Sales 2021 4,37x
Nbr of Employees 88 300
Free-Float 59,1%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
02/02Earnings Release
More about the company
All news about PFIZER INC.
05:07aPFIZER : Vaccinating a Country in 100 Days
AQ
11/28UK secures 2 million more doses of Moderna's COVID-19 vaccine
RE
11/28UK says tough tiers needed as PM tries to see off lawmaker backlash
RE
11/28Serum Institute CEO sees AstraZeneca's COVID-19 vaccine as "very good" candid..
RE
11/28Serum Institute CEO sees AstraZeneca's COVID-19 vaccine as "very good" candid..
RE
11/28UK regulator set to approve COVID-19 vaccine next week - FT
RE
11/28UK regulator set to approve COVID-19 vaccine next week - FT
RE
11/28UK appoints vaccines minister to oversee COVID inoculations
AQ
11/27Wall Street Week Ahead: COVID-19 vaccine adoption rates are 'wildcard' for U...
RE
11/27SALESFORCE, DELTA AIR LINES, BEST BU : Stocks That Defined the Week
DJ
11/27PFIZER : A look at what provinces and territories have said about COVID-19 vacci..
AQ
11/27United Begins Flying Pfizer's Covid-19 Vaccine -- Update
DJ
11/27Wall St. gains, Nasdaq hits record high as holiday shopping begins
RE
11/27Ten COVID-19 vaccines seen by mid-year, head of global pharma group says
RE
11/27Vaccine Approval Race Gears Up as U.K. Asks for Emergency Review of AstraZene..
DJ
More news
News in other languages on PFIZER INC.
06:15aCOVID-19 : qui vacciner en priorité ? La Haute autorité de santé rend ses
11/28VACCINS : le seul fournisseur français de congélateurs médicaux sur le pied de
11/28ALLEMAGNE : un des plus grands "hubs" mondiaux se prépare au transport du vaccin
11/28SPOUTNIK V : pour les vaccins aussi, la Hongrie fait bande à part
11/27COVID-19 : un général va coordonner la distribution des vaccins au Canada
More news
Analyst Recommendations on PFIZER INC.
More recommendations
Stock Trading Strategies
PFIZER INC. - 10/20
Close to new upside potential
BUY
More Stock Trading Analysis
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 42,15 $
Last Close Price 37,23 $
Spread / Highest target 47,7%
Spread / Average Target 13,2%
Spread / Lowest Target -5,99%
EPS Revisions
Managers
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Wyllie Don Cornwell Independent Director
Suzanne Nora Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.0.30%206 939
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440